AI Collaboration And Aging Trends Will Expand Autoimmune Biologics Markets
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 14 Analysts
Published
23 Aug 25
Updated
23 Aug 25
AnalystHighTarget's Fair Value
€806.00
26.8% undervalued intrinsic discount23 Aug
€590.00
1Y
26.3%7D
2.9%1Y
26.3%7D
2.9%